According to a recent LinkedIn post from Oshi Health, the company is emphasizing the gap in gastrointestinal care access across the U.S. and positioning its clinician-led virtual GI model as a response. The post cites data that two-thirds of U.S. counties lack practicing gastroenterologists while around 15% of covered lives seek GI care annually, often without a clear diagnosis.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The company’s LinkedIn post highlights a breakdown by CEO Sam Holliday of a PHTI report on virtual GI solutions, focusing on whether such offerings can serve employees regardless of local specialist supply. The message suggests that only clinician-led virtual care can fully manage GI conditions remotely, including diagnosis, prescribing, and ongoing treatment iteration.
For investors, this positioning points to Oshi Health targeting a structurally underserved specialty area where virtual care may be able to capture demand that traditional brick-and-mortar providers cannot. If payers and benefits leaders adopt solutions that work in low-supply regions, Oshi could see expanded covered lives, improved utilization, and potentially stronger revenue visibility in employer and health-plan channels.
The emphasis on clinician-led care also implies a higher-acuity, higher-value service model relative to purely wellness- or navigation-focused digital tools. This could support premium pricing or value-based contracts, though it may also entail higher operating costs and regulatory complexity, factors investors would need to weigh against the growth opportunity in GI access and digital health more broadly.

